Article
Reformation provides IOP control more safely
Austin, TX-Brimonidine-Purite 0.15% (Alphagan P, Allergan), a new formulation of brimonidine tartrate ophthalmic solution in which benzalkonium chloride has been replaced with Purite, offers IOP-lowering efficacy comparable to brimonidine 0.2% (Alphagan) with the benefit of a superior safety profile, said Thomas R. Walters, MD.
Related Videos
Related Content
